Last Updated: May 10, 2026

Claims for Patent: 11,135,249

✉ Email this page to a colleague

Summary for Patent: 11,135,249

Title:	Methods for increasing osteoblastic function
Abstract:	This application provides methods for treating a human subject suffering from a bone fracture by administering to the subject a population of cells enriched from STRO-1+ multipotential cells and/or multipotential progeny of such cells.
Inventor(s):	Silviu Itescu, Ravi Krishnan
Assignee:	Mesoblast Inc
Application Number:	US16/460,734

Details for Patent 11,135,249

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	September 25, 2009	11,135,249	2039-07-02
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	125261	December 30, 2009	11,135,249	2039-07-02
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	October 21, 2013	11,135,249	2039-07-02
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	November 19, 2018	11,135,249	2039-07-02
Genentech, Inc.	SUSVIMO	ranibizumab	Injection	761197	October 22, 2021	11,135,249	2039-07-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,135,249

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2013033777	⤷ Start Trial
United States of America	9642878	⤷ Start Trial
United States of America	2019343887	⤷ Start Trial
United States of America	2017274016	⤷ Start Trial
United States of America	2014363404	⤷ Start Trial
Turkey	201809635	⤷ Start Trial
Singapore	11201400218Y	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.